Last updated: December 6, 2017
Sponsor: Nanfang Hospital of Southern Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chemotherapy
Red Blood Cell Disorders
Platelet Disorders
Treatment
N/AClinical Study ID
NCT02850822
Therapy vs Notherapy-MDS-2016
Ages 14-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
RAEB-1, REAB-2 and AML Secondary to MDS (Bone marrow blast cells less than 50%)undergoing allo-HSCT
14-65 years
Exclusion
Exclusion Criteria:
Any abnormality in a vital sign (e.g., heart rate, respiratory rate, or bloodpressure)
Patients with any conditions not suitable for the trial (investigators' decision)
Study Design
Total Participants: 250
Study Start date:
July 01, 2016
Estimated Completion Date:
June 30, 2020
Study Description
Connect with a study center
Department of Hematology,Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong 510515
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.